Maze Therapeutics: Dandekar buys 7500 shares, sells 8800 shares on 2026-01-29.

Maze Therapeutics, Inc. (MAZE) recently disclosed that Atul Dandekar, Chief Scientific Officer, has engaged in a series of transactions involving the purchase and sale of shares. Specifically, Mr. Dandekar purchased 7,500 shares at $10.42 per share on January 29, 2026. Subsequently, he sold 2,800 shares at $45.01 per share, 1,200 shares at $43.18 per share, and 3,500 shares at $44.04 per share on the same day.